162 related articles for article (PubMed ID: 14513676)
1. Stimuli-responsive gene delivery vectors.
Oupický D; Diwadkar V
Curr Opin Mol Ther; 2003 Aug; 5(4):345-50. PubMed ID: 14513676
[TBL] [Abstract][Full Text] [Related]
2. Methods of local gene delivery to vascular tissues.
March KL
Semin Interv Cardiol; 1996 Sep; 1(3):215-23. PubMed ID: 9552514
[TBL] [Abstract][Full Text] [Related]
3. [The biosafety of non-viral gene delivery vectors].
Yang J; Zhu D; Leng X; Zhang H; Song L; Yao K
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):215-9. PubMed ID: 18435294
[TBL] [Abstract][Full Text] [Related]
4. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
Kaneda Y
Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-responsive polymers in gene delivery.
Piskin E
Expert Rev Med Devices; 2005 Jul; 2(4):501-9. PubMed ID: 16293088
[TBL] [Abstract][Full Text] [Related]
6. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.
Maheshri N; Koerber JT; Kaspar BK; Schaffer DV
Nat Biotechnol; 2006 Feb; 24(2):198-204. PubMed ID: 16429148
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
Blankinship MJ; Gregorevic P; Chamberlain JS
Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
[TBL] [Abstract][Full Text] [Related]
8. Cell-selective viral gene delivery vectors for the vasculature.
Baker AH; Kritz A; Work LM; Nicklin SA
Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.
Labhasetwar V
Curr Opin Biotechnol; 2005 Dec; 16(6):674-80. PubMed ID: 16263259
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
11. Barriers to gene delivery using synthetic vectors.
Read ML; Logan A; Seymour LW
Adv Genet; 2005; 53():19-46. PubMed ID: 16240989
[TBL] [Abstract][Full Text] [Related]
12. Engineering chromosomes for delivery of therapeutic genes.
Irvine DV; Shaw ML; Choo KH; Saffery R
Trends Biotechnol; 2005 Dec; 23(12):575-83. PubMed ID: 16242803
[TBL] [Abstract][Full Text] [Related]
13. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
Douglas KL
Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
[TBL] [Abstract][Full Text] [Related]
14. Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement.
Wang Y; Yuan F
Ann Biomed Eng; 2006 Jan; 34(1):114-27. PubMed ID: 16520902
[TBL] [Abstract][Full Text] [Related]
15. Approaches to improving the kinetics of adenovirus-delivered genes and gene products.
Xu ZL; Mizuguchi H; Sakurai F; Koizumi N; Hosono T; Kawabata K; Watanabe Y; Yamaguchi T; Hayakawa T
Adv Drug Deliv Rev; 2005 Apr; 57(5):781-802. PubMed ID: 15757761
[TBL] [Abstract][Full Text] [Related]
16. In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administration.
Bahi A; Boyer F; Gumy C; Kafri T; Dreyer JL
Eur J Neurosci; 2004 Dec; 20(12):3473-88. PubMed ID: 15610180
[TBL] [Abstract][Full Text] [Related]
17. Artificial and engineered chromosomes: non-integrating vectors for gene therapy.
Basu J; Willard HF
Trends Mol Med; 2005 May; 11(5):251-8. PubMed ID: 15882613
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery.
Dobson J
Gene Ther; 2006 Feb; 13(4):283-7. PubMed ID: 16462855
[TBL] [Abstract][Full Text] [Related]
19. Polymers for gene delivery across length scales.
Putnam D
Nat Mater; 2006 Jun; 5(6):439-51. PubMed ID: 16738681
[TBL] [Abstract][Full Text] [Related]
20. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
